Mycosis Fungoides News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Mycosis Fungoides - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ... - Business Wire (press release)



Mycosis Fungoides - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ... 
Business Wire (press release)
Mycosis Fungoides - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018' report provides comprehensive insights about marketed and Phase III products for Mycosis Fungoides . The report includes information of marketed products ...

and more » 


miRagen Therapeutics Presents New Data from Phase 1 Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell ... - GlobeNewswire (press release)



GlobeNewswire (press release)
 
miRagen Therapeutics Presents New Data from Phase 1 Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell ... 
GlobeNewswire (press release)
02, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced new interim data from its Phase 1 clinical trial of MRG-106 ...
Early-stage data positive for miRagen's MRG-106 Seeking Alpha
miRagen Therapeutics Inc Receives a Buy from Oppenheimer Analyst Ratings

all 12 news articles » 


90% of Mycosis Fungoides Patients Improved After MRG-106 Treatment, Study Shows - Lymphoma News Today



Lymphoma News Today
 
90% of Mycosis Fungoides Patients Improved After MRG-106 Treatment, Study Shows 
Lymphoma News Today
The 29 mycosis fungoides participants received weekly doses of MRG-106 ? 300 mg, 600 mg and 900 mg ? delivered subcutaneously (under the skin) or intravenously (directly into the blood), or via intravenous bolus injection, which administers the therapy ...

 


Mycosis Fungoides Market 2018 Pipeline therapeutics, Comprehensive Development Analysis in a Latest Research - The Financial



Mycosis Fungoides Market 2018 Pipeline therapeutics, Comprehensive Development Analysis in a Latest Research 
The Financial
Mycosis Fungoides Market Pipeline therapeutics 2018 presents an in-depth assessment of the pipeline (under development) therapeutics scenario and growth prospects across Mycosis Fungoides Market development. The report additionally provides detailed ...

and more » 


Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell ... - Dove Medical Press



Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell ... 
Dove Medical Press
Abstract: Nitrogen mustard is a chemotherapeutic agent that has a well-documented safety and efficacy profile in the treatment of cutaneous T-cell lymphoma. Development of nitrogen mustard formulations and treatment regimens has been studied ...

and more » 


Mycosis Fungoides Market Treatment Guidelines, Differences Epidemiology Patterns and Consulting Services - The Financial



Mycosis Fungoides Market Treatment Guidelines, Differences Epidemiology Patterns and Consulting Services 
The Financial
Mycosis Fungoides Market Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ? marketed, Phase III products, Drugs Profiles and route of synthesis. The Mycosis Fungoides Market report is an in-depth market study providing accurate ...

and more » 


Mycosis Fungoides Industry Overview with Total Market Share and Distribution of Mycosis Fungoides for 7 MM for 2027 - The Financial



Mycosis Fungoides Industry Overview with Total Market Share and Distribution of Mycosis Fungoides for 7 MM for 2027 
The Financial
Mycosis Fungoides ? Market Insights, Epidemiology and Market Forecast ? 2027?? report provides a detailed analysis of the Mycosis Fungoides epidemiology and market outlook for the 7MM.United States, EU5 (Germany, France, Italy, Spain, and the United ...
Mycosis Fungoides Market Epidemiology, Drug Description, Mechanism of Action, Regulatory Milestones and Forecast ... MilTech

all 34 news articles » 


Mycosis Fungoides Market Epidemiology, Overview, Symptoms, Risk Factors, Product Profiles & Analysis 2027 - Investor Opinion



Mycosis Fungoides Market Epidemiology, Overview, Symptoms, Risk Factors, Product Profiles & Analysis 2027 
Investor Opinion
Mycosis Fungoides Market Epidemiology and Market Forecast 2027, in-depth analysis of the Mycosis Fungoides Industry epidemiology and market outlook for the 7MM. The report provides the overview of the Mycosis Fungoides Market by the disease overview ...

and more » 


Miragen Therapeutics (NASDAQ:MGEN) Stock Rating Reaffirmed by Cann - Week Herald



Week Herald
 
Miragen Therapeutics (NASDAQ:MGEN) Stock Rating Reaffirmed by Cann 
Week Herald
Miragen Therapeutics (NASDAQ:MGEN)'s stock had its ?buy? rating reissued by equities researchers at Cann in a report released on Friday, February 2nd. They currently have a $13.00 price objective on the medical research company's stock. Cann's price ...

and more » 


Mycosis Fungoides Industry Production, Sales and Consumption Status and Prospects Market Research Report - The Columnist



Mycosis Fungoides Industry Production, Sales and Consumption Status and Prospects Market Research Report 
The Columnist
Mycosis Fungoides Market Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ? marketed, Phase III products, Drugs Profiles and route of synthesis. The Mycosis Fungoides Market report is an in-depth market study providing accurate ...

and more »